Arcutis Biotherapeutics ARQT
NASDAQ ARQT
$26.80 +0.05 (+0.19%)
As of: Sep 30, 2026 · 1:26 PM EDT

Arcutis Biotherapeutics, Inc. (ARQT) Short term Debt (2024 - 2026)

Updated

Arcutis Biotherapeutics' Short term Debt was $6.95 million in Q2 2026, up 595.0% from $1 million a year earlier but down 12.6% from the prior quarter.

Analysis

Arcutis Biotherapeutics, Inc. (ARQT) Short term Debt (2024 - 2026) Analysis & Trends

At the end of FY2025, Short term Debt at Arcutis Biotherapeutics came in at $1 million.

  • Quarterly Short term Debt has moved between $1 million (Q2 2025) and $99.51 million (Q3 2024) over five years.
  • Per Business Quant data, ARQT's Short term Debt in the three quarters before Q2 2026 was $7.95 million (Q1 2026), $1 million (Q4 2025) and $1 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.95 Mn
Mar 31, 2026 7.95 Mn
Dec 31, 2025 1.00 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 1.00 Mn
Sep 30, 2024 99.51 Mn
API Access

Arcutis Biotherapeutics, Inc. Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ARQT&period=max&api_key=YOUR_API_KEY